Long-Term Safety of Hydrocodone Bitartrate in Patients Who Require Opioid Treatment
- Study Title
- Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time
- Teva Identifier
- C33237/3080
- ClinicalTrials.gov Identifier
- NCT01223365
- Study Status
- Completed
- Trial Condition(s)
- Chronic Pain
- Interventions
- Drug: Hydrocodone ER
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 80 Years
- Trial Duration
- 10/01/2010 - 09/01/2012
- Phase
- Phase 3
